Peter A. Thompson Transaction History

Date Transaction Value Shares Traded Form
Aug 26 2024
SELL
Open market or private sale
$1,088,035 $13.0 p/Share
83,695
Aug 23 2024
SELL
Open market or private sale
$905,585 $13.03 p/Share
69,500
Aug 22 2024
SELL
Open market or private sale
$5,065,777 $12.94 p/Share
391,482
Aug 21 2024
SELL
Open market or private sale
$5,736,339 $14.07 p/Share
407,700
Aug 29 2023
BUY
Open market or private purchase
$3,100,000 $6.2 p/Share
500,000
Dec 08 2020
BUY
Conversion of derivative security
-
7,011,765
Dec 08 2020
BUY
Open market or private purchase
$25,000,017 $21.0 p/Share
1,190,477

Also insider at

ALPN
ALPINE IMMUNE SCIENCES, INC. Healthcare
PRVL
Prevail Therapeutics Inc.
DBTX
Decibel Therapeutics, Inc. Healthcare
CRVS
Corvus Pharmaceuticals, Inc. Healthcare
EWTX
Edgewise Therapeutics, Inc. Healthcare
PMVP
PMV Pharmaceuticals, Inc. Healthcare
JANX
Janux Therapeutics, Inc. Healthcare
PAT

Peter A. Thompson

Director
Burlingame, CA

Track Institutional and Insider Activities on SBTX

Follow Silverback Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SBTX shares.

Notify only if

Insider Trading

Get notified when an Silverback Therapeutics, Inc. insider buys or sells SBTX shares.

Notify only if

News

Receive news related to Silverback Therapeutics, Inc.

Track Activities on SBTX